Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

A leading bioethicist offers critical insights into the scientific, ethical, and political implications of human genome editing.

Designer babies, once found only in science fiction, have become a reality. We are entering a new era of human evolution with the advent of a technology called CRISPR, which allows scientists to modify our genes. Although CRISPR shows great promise for therapeutic use, it raises thorny ethical, legal, political, and societal concerns because it can be used to make permanent changes to future generations. What if changes intended for the good turn out to have unforeseen negative effects? What if the divide between the haves and have-nots widens as a result? Who decides whether we genetically modify human beings and, if so, how?

Françoise Baylis insists that we must all have a role in determining our future as a species. The scientists who develop and use genome-editing tools should not be the only ones making decisions about future uses of the technology. Such decisions must be the fruit of a broad societal consensus. Baylis argues that it is in our collective interest to assess and steer the development and implementation of biomedical technologies. Members of the public with different interests and diverse perspectives must be among the decision makers; only in this way can we ensure that societal concerns are taken into account and that responsible decisions are made. We must be engaged and informed, think critically, and raise our voices as we create our future together.

Sharp, rousing, timely, and thought-provoking, Altered Inheritance is essential reading. The future of humanity is in our hands.

"1130806762"
Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

A leading bioethicist offers critical insights into the scientific, ethical, and political implications of human genome editing.

Designer babies, once found only in science fiction, have become a reality. We are entering a new era of human evolution with the advent of a technology called CRISPR, which allows scientists to modify our genes. Although CRISPR shows great promise for therapeutic use, it raises thorny ethical, legal, political, and societal concerns because it can be used to make permanent changes to future generations. What if changes intended for the good turn out to have unforeseen negative effects? What if the divide between the haves and have-nots widens as a result? Who decides whether we genetically modify human beings and, if so, how?

Françoise Baylis insists that we must all have a role in determining our future as a species. The scientists who develop and use genome-editing tools should not be the only ones making decisions about future uses of the technology. Such decisions must be the fruit of a broad societal consensus. Baylis argues that it is in our collective interest to assess and steer the development and implementation of biomedical technologies. Members of the public with different interests and diverse perspectives must be among the decision makers; only in this way can we ensure that societal concerns are taken into account and that responsible decisions are made. We must be engaged and informed, think critically, and raise our voices as we create our future together.

Sharp, rousing, timely, and thought-provoking, Altered Inheritance is essential reading. The future of humanity is in our hands.

18.99 In Stock
Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

by Françoise Baylis
Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

Altered Inheritance: CRISPR and the Ethics of Human Genome Editing

by Françoise Baylis

eBook

$18.99  $24.95 Save 24% Current price is $18.99, Original price is $24.95. You Save 24%.

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

A leading bioethicist offers critical insights into the scientific, ethical, and political implications of human genome editing.

Designer babies, once found only in science fiction, have become a reality. We are entering a new era of human evolution with the advent of a technology called CRISPR, which allows scientists to modify our genes. Although CRISPR shows great promise for therapeutic use, it raises thorny ethical, legal, political, and societal concerns because it can be used to make permanent changes to future generations. What if changes intended for the good turn out to have unforeseen negative effects? What if the divide between the haves and have-nots widens as a result? Who decides whether we genetically modify human beings and, if so, how?

Françoise Baylis insists that we must all have a role in determining our future as a species. The scientists who develop and use genome-editing tools should not be the only ones making decisions about future uses of the technology. Such decisions must be the fruit of a broad societal consensus. Baylis argues that it is in our collective interest to assess and steer the development and implementation of biomedical technologies. Members of the public with different interests and diverse perspectives must be among the decision makers; only in this way can we ensure that societal concerns are taken into account and that responsible decisions are made. We must be engaged and informed, think critically, and raise our voices as we create our future together.

Sharp, rousing, timely, and thought-provoking, Altered Inheritance is essential reading. The future of humanity is in our hands.


Product Details

ISBN-13: 9780674241961
Publisher: Harvard University Press
Publication date: 09/17/2019
Sold by: Barnes & Noble
Format: eBook
Pages: 240
File size: 5 MB

About the Author

Françoise Baylis is University Research Professor at Dalhousie University. She is a member of the Order of Canada and the Order of Nova Scotia, as well as a fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Baylis was a key participant in the 2015 International Summit on Human Gene Editing and is a member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. She was awarded the Killam Prize from the Canada Council for the Arts for her work in science humanities.

Table of Contents

Cover Title Page Copyright Dedication Contents Prologue��������������� 1. Targeting a Single Gene: Huntington’s Disease 2. From Editing a Genome to Altering Inheritance 3. Babies by Design 4. From “Well” to “Better than Well" 5. Ethics in the Interim 6. Of Harms and Wrongs 7. Slow Science 8. Scientists, Science Policy, and Politics 9. Ethicists, Science Policy, and Politics 10. “All of Us” for “Us All" Epilogue: A New Dawn��������������������������� Abbreviations�������������������� Glossary��������������� Notes������������ Acknowledgments���������������������� Index������������
From the B&N Reads Blog

Customer Reviews